DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Stadler WM, Figlin RA, Ernstoff MS, Curti B, Pendergrass K, Srinivas S, Canfield V, Weissman C, Poulin-Costello M, Bukowski RM. investigators. obotA.
The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded
access trial: Safety and efficacy in patients (pts) with non-clear cell (NCC)
renal cell carcinoma (RCC).
J Clin Oncol 2007;
25.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.